212 related articles for article (PubMed ID: 21274875)
41. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
42. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats.
Park PH; Nan JX; Park EJ; Kang HC; Kim JY; Ko G; Sohn DH
Pharmacol Toxicol; 2000 Dec; 87(6):261-8. PubMed ID: 11140824
[TBL] [Abstract][Full Text] [Related]
43. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
44. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
45. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
46. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
47. Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
Assis DN; Abdelghany O; Cai SY; Gossard AA; Eaton JE; Keach JC; Deng Y; Setchell KD; Ciarleglio M; Lindor KD; Boyer JL
J Clin Gastroenterol; 2017 Feb; 51(2):e11-e16. PubMed ID: 27428727
[TBL] [Abstract][Full Text] [Related]
48. Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease.
Ljubuncic P; Tanne Z; Bomzon A
Dig Dis Sci; 2000 Oct; 45(10):1921-8. PubMed ID: 11117561
[TBL] [Abstract][Full Text] [Related]
49. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
[TBL] [Abstract][Full Text] [Related]
50. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
51. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
52. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.
Xia JL; Dai C; Michalopoulos GK; Liu Y
Am J Pathol; 2006 May; 168(5):1500-12. PubMed ID: 16651617
[TBL] [Abstract][Full Text] [Related]
54. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
[TBL] [Abstract][Full Text] [Related]
55. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
56. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
57. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
[TBL] [Abstract][Full Text] [Related]
58. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
59. Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.
Myung SJ; Yoon JH; Gwak GY; Kim W; Yang JI; Lee SH; Jang JJ; Lee HS
Biochem Biophys Res Commun; 2007 Feb; 353(4):1091-6. PubMed ID: 17204245
[TBL] [Abstract][Full Text] [Related]
60. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
